Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (11): 695-696.
DOI: 10.19803/j.1672-8629.2019.11.11
Previous Articles Next Articles
LIU Xiaoli, LIU Yajuan, CAO Yidan, SONG Yanqing, WANG Xiangfeng*
Received:2019-11-27
Revised:2019-11-27
Online:2019-11-20
Published:2019-11-27
CLC Number:
LIU Xiaoli, LIU Yajuan, CAO Yidan, SONG Yanqing, WANG Xiangfeng. One Case of Systemic Urticaria Complicated with Dyspnea Induced by Moxifloxacin Hydrochloride Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(11): 695-696.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.11.11
| [1] 赵东玲,屈清慧,李瑞林,等. 莫西沙星致不良反应3445例文献分析[J]. 中国药房, 2015, 26(21) :2913-2915. [2] 郑芸颖,王华光,陈罡,等. 莫西沙星注射液导致全身皮疹的迟发型过敏反应[J]. 中国临床药理学杂志, 2018,23(34):2775-2777. [3] 卢姗,李立,石蕊,等. 盐酸莫西沙星注射液致静脉炎1例[J]. 中国药师, 2018, 5(21):887-888. [4] 杨晓娟,关月,恽艳琴,等. 我院33例莫西沙星不良反应分析[J]. 中国药师, 2018, 12(21):2192-2195. [5] 李远,孙溆棋,张良海,等. 莫西沙星致不良反应165例分析[J]. 药物流行病学杂志, 2014, 7(23):428-430. [6] Culley C M, Lacy M K, Klutman N, et al.Moxifloxacin: clinicaleffica-cy and safety[J]. Am J Health Syst Pharm, 2001,58(5): 379-388. [7] 刘建平. 生物药剂学与药物动力学[M]. 北京:人民卫生出版社,2017年:107. [8] CHERER K,BIRCHER A J.Hypersensitivity reactionsto fluoro-quinolones[J]. Curr Allergy Asthma Rep,2005,25(5):15-21. [9] 许红玮,郑弘. 莫西沙星不良反应70例文献分析[J]. 中国药房,2010,21(36):3433-3434. [10] 祁琳. 莫西沙星引起的不良反应及分析[C]//2012年中国药学大会暨第十二届中国药师周论文集.北京:中国药学会,2012:3. [11] 李新. 左氧氟沙星致呼吸困难等不良反应1例[J]. 天津药学,2007,5(19):40-41. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
